These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37071763)

  • 1. Pathologic and Immunophenotypic Characterization of Syncytial Giant Cell Variant of Pediatric Hepatocellular Carcinoma. A Distinct Subtype.
    Vij M; Menon J; Subbiah K; Raju LP; Gowrisankar G; Shanmugum N; Kaliamoorthy I; Rammohan A; Rela M
    Fetal Pediatr Pathol; 2023 Aug; 42(4):709-718. PubMed ID: 37071763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma, syncytial giant cell: a novel variant in children: a case report.
    Atra A; Al-Asiri R; Wali S; Al-Husseini H; Al-Bassas A; Zimmermann A
    Ann Diagn Pathol; 2007 Feb; 11(1):61-3. PubMed ID: 17240310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood hepatocellular carcinoma: a clinicopathological study of 12 cases with special reference to EpCAM.
    Zen Y; Vara R; Portmann B; Hadzic N
    Histopathology; 2014 Apr; 64(5):671-82. PubMed ID: 24138022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma in biliary atresia: King's College Hospital experience.
    Hadžić N; Quaglia A; Portmann B; Paramalingam S; Heaton ND; Rela M; Mieli-Vergani G; Davenport M
    J Pediatr; 2011 Oct; 159(4):617-22.e1. PubMed ID: 21489554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
    Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
    Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early occurrence of hepatocellular carcinoma in biliary atresia treated by liver transplantation.
    Brunati A; Feruzi Z; Sokal E; Smets F; Fervaille C; Gosseye S; Clapuyt P; de Ville de Goyet J; Reding R
    Pediatr Transplant; 2007 Feb; 11(1):117-9. PubMed ID: 17239135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
    Allam N; Khalaf H; Fagih M; Al-Sebayel M
    Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
    Kemmer N; Neff G; Kaiser T; Zacharias V; Thomas M; Tevar A; Satwah S; Shukla R; Buell J
    Liver Transpl; 2006 Oct; 12(10):1519-22. PubMed ID: 17004260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma.
    Guo Z; Li LQ; Jiang JH; Ou C; Zeng LX; Xiang BD
    World J Gastroenterol; 2014 Feb; 20(8):2098-106. PubMed ID: 24616575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Hepatocellular Carcinoma.
    Varol Fİ
    J Gastrointest Cancer; 2020 Dec; 51(4):1169-1175. PubMed ID: 32856229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical evaluation of a sarcomatoid hepatocellular carcinoma with osteoclastlike giant cells.
    Dahm HH
    Diagn Pathol; 2015 Apr; 10():40. PubMed ID: 25928039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New case of syncytial giant-cell variant of hepatocellular carcinoma in a pediatric patient with
    Pinon M; Gambella A; Giugliano L; Chiadò C; Kalantari S; Bracciamà V; Deaglio S; Tinti D; Peruzzi L; Cotti R; Catalano S; Cadamuro M; Fabris L; Calvo PL; Romagnoli R
    BMJ Open Gastroenterol; 2022 Dec; 9(1):. PubMed ID: 36572455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Pathologic Stratification of Microvascular Invasion in Hepatocellular Carcinoma: Predicting Prognosis After Living-donor Liver Transplantation.
    Iguchi T; Shirabe K; Aishima S; Wang H; Fujita N; Ninomiya M; Yamashita Y; Ikegami T; Uchiyama H; Yoshizumi T; Oda Y; Maehara Y
    Transplantation; 2015 Jun; 99(6):1236-42. PubMed ID: 25427164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma complicating biliary atresia after Kasai portoenterostomy.
    Hol L; van den Bos IC; Hussain SM; Zondervan PE; de Man RA
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):227-31. PubMed ID: 18301305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma in a 10-month-old biliary atresia child.
    Iida T; Zendejas IR; Kayler LK; Magliocca JF; Kim RD; Hemming AW; Gonzalez-Peralta RP; Fujita S
    Pediatr Transplant; 2009 Dec; 13(8):1048-9. PubMed ID: 19032418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharyngeal metastasis following living-donor liver transplantation for hepatocellular carcinoma: a case report and literature review.
    Tohyama T; Sakamoto K; Tamura K; Nakamura T; Watanabe J; Wakisaka H; Takada Y
    World J Surg Oncol; 2020 May; 18(1):109. PubMed ID: 32466780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma in an infant with biliary atresia younger than 1 year.
    Kim JM; Lee SK; Kwon CH; Joh JW; Choe YH; Park CK
    J Pediatr Surg; 2012 Apr; 47(4):819-21. PubMed ID: 22498405
    [No Abstract]   [Full Text] [Related]  

  • 18. Living Donor Liver Transplantation: The Optimal Curative Treatment for Hepatocellular Carcinoma Even Beyond Milan Criteria.
    Alim A; Erdogan Y; Dayangac M; Yuzer Y; Tokat Y; Oezcelik A
    Cancer Control; 2021; 28():10732748211011960. PubMed ID: 33926242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome.
    Arikan C; Kilic M; Nart D; Ozgenc F; Ozkan T; Tokat Y; Yagci RV; Aydogdu S
    Pediatr Transplant; 2006 Feb; 10(1):42-7. PubMed ID: 16499586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma.
    Zeng SS; Yamashita T; Kondo M; Nio K; Hayashi T; Hara Y; Nomura Y; Yoshida M; Hayashi T; Oishi N; Ikeda H; Honda M; Kaneko S
    J Hepatol; 2014 Jan; 60(1):127-34. PubMed ID: 24012616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.